BB1 Share Price Performance
AU$0.69
0.43 (163.46%)
Price AU$0.69
Share PriceAU$0.69
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations. The company’s application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.